Ezrin… a metastatic detERMinant?

Slides:

Advertisements

Similar presentations

Un Ménage à Quatre Mark Petronczki, Maria F Siomos, Kim Nasmyth Cell Volume 112, Issue 4, Pages (February 2003) DOI: /S (03)

Advertisements

Lessons from Hereditary Colorectal Cancer

Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals Xiang H.-F. Zhang, Qiongqing Wang, William Gerald, Clifford A. Hudis, Larry.

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr

Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.

Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.

Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem

Cultured Schwann Cells Constitutively Express the Myelin Protein P0 Lili Cheng, Anne W Mudge Neuron Volume 16, Issue 2, Pages (February 1996) DOI:

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)

Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer – A retrospective single institution analysis.

A Hole in the Heart Journal of Thoracic Oncology

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

PUBLISH ONLY Journal of Thoracic Oncology

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Infections related to totally implantable venous-access ports

Metastasis gets site specific

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Cell signaling and cancer

Biology and Clinical Applications of Pancreatic Cancer Stem Cells

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901 Stephen L. Graziano,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.

When LMO1 Meets MYCN, Neuroblastoma Is Metastatic

Gastroenterology news

Volume 4, Issue 1, Pages 4-6 (July 2003)

Taking the Study of Cancer Cell Survival to a New Dimension

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

Volume 6, Issue 3, Pages (September 2004)

Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer Daniel Morgensztern, MD, Saiama.

Heike Döppler, Peter Storz Cell Metabolism

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Vascular Endothelial Growth Factor (VEGF) Pathway

Characterizing the Killer Colorectal Carcinomas

LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Inflammation Joins the “Niche”

Reprogramming Enhancers to Drive Metastasis

Prevention and Management of Bone Metastases in Lung Cancer: A Review

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

An Updated Meta-Analysis of Randomized Controlled Trials Comparing Irinotecan/Platinum with Etoposide/Platinum in Patients with Previously Untreated.

Late Mediastinal Hematoma Followed by Incisional Metastasis After Video-Assisted Mediastinoscopy Daniel Pop, MD, Ahmad S. Nadeemy, MD, Nicolas Venissac,

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

A Hole in the Heart Journal of Thoracic Oncology

PUBLISH ONLY Journal of Thoracic Oncology

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Erratum Journal of Thoracic Oncology

Vamsidhar Velcheti, MD Journal of Thoracic Oncology

Mitotic Inhibitors Journal of Thoracic Oncology

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers Jules L. Derks, MD Journal of.

Volume 17, Issue 2, Pages (February 1950)

The Feasibility of Adjuvant Carboplatin and Docetaxel in Patients with Curatively Resected Non-small Cell Lung Cancer Thomas E. Stinchcombe, MD, Harry.

Volume 22, Issue 18, Pages R784-R785 (September 2012)

Infections related to totally implantable venous-access ports

Iris Metastasis from Small-Cell Lung Cancer

A2-06: Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis.

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Regina M. Vidaver, PhD, Beth S. Schachter, PhD

The new kid on the block(ade) of the IGF-1 receptor

Volume 4, Issue 1, Pages 2-3 (February 2006)

PP2A fulfills its promises as tumor suppressor

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

A Review of First-Line Treatment for Small-cell Lung Cancer

Outcome after Pulmonary Metastasectomy: Analysis of 5 Years Consecutive Surgical Resections 2002–2006 Kåre Hornbech, MD, Jesper Ravn, MD, Daniel Andreas.

Elevated Preoperative C-reactive Protein Predicts Poor Cancer Specific Survival in Patients Undergoing Resection for Non-small Cell Lung Cancer Caroline.

Presentation transcript:

Ezrin… a metastatic detERMinant? Marcello Curto, Andrea I McClatchey Cancer Cell Volume 5, Issue 2, Pages 113-114 (February 2004) DOI: 10.1016/S1535-6108(04)00031-5

Figure 1 A well-established osteosarcoma metastasis in the lung of an Nf2+/− mouse OSM, osteosarcoma metastasis; L, lung parenchyma. Note the boundary between the metastasis and lung parenchyma (*). Here, osteoid cells survive, proliferate, and migrate into a foreign milieu. Cancer Cell 2004 5, 113-114DOI: (10.1016/S1535-6108(04)00031-5)